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The appendix contains copious lymphoid tissue and is constantly exposed to gut flora. Appendicitis and
appendectomy (AA) has been shown to prevent or significantly ameliorate ulcerative colitis. In our novel murine
AA model, the only existing experimental model of AA, the appendiceal pathology closely resembles that of
human appendicitis; and AA offers an age-, bacteria- and antigen-dependent protection against colitis. Appendicitis
and appendectomy performed in the most proximal colon curbs T helper 17 cell activity, curtails autophagy, modulates
interferon activity-associated molecules, and suppresses endothelin vasoactivity-mediated immunopathology/vascular
remodelling in the most distal colon. These AA-induced changes contribute to the limitation/amelioration of colitis
pathology. Investigating strategies to manipulate and modulate different aspects of these pathways (using monoclonal
antibodies, combinatorial peptides, and small molecules) would offer novel insight into inflammatory bowel disease
pathogenesis, and will augment the development of new therapeutic options to manage recalcitrant colitis.
Keywords: Appendicitis, Appendectomy, Inflammatory bowel disease, Colitis, Autophagy, Antigen-processingAppendicitis-appendectomy and inflammatory
bowel diseases
The vermiform appendix or simply the appendix, con-
tains copious lymphoid tissue and is constantly exposed
to gastrointestinal bacteria. Appendicitis is the most
common abdominal emergency requiring surgery [1], its
highest occurrence being between 10 and 30 years [2].
As succinctly summarised and critically appraised/
re-analysed by Koutroubakis et al. [3,4], and in over a
dozen individual clinical studies [4-17], Appendicitis
and appendectomy (AA) has been shown to prevent or
significantly ameliorate ulcerative colitis. This intri-
guing phenomenon was demonstrable only in patients
who had undergone appendectomy prior to 20 years of
age. AA has also shown to be protective against Crohn’s
disease in a few studies [16,18]. However, other studies
[11,19-21] have showed a slightly elevated risk early after
appendectomy, but this has been clearly attributed toCorrespondence: rajkumarchel@gmail.com
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unless otherwise stated.diagnostic bias (misdiagnosis of early Crohn’s disease as
appendicitis) by these studies.
Procedure overview and rationale minutiae - mouse
model of appendicitis and appendectomy, and
tissue processing
(1) In mice, the major caecal lymphoid patch is the
equivalent of the human appendix (Figure 1). In our
AA model, the appendiceal pathology closely
resembles that of human appendicitis; and AA
offeres an age-, bacteria- and antigen-dependent
protection against TNBS-colitis [22].
(2) Balb/c mice (Male, 5 weeks), are intraperitonealy
anaesthetised with xylazine (5mg/kg; Sigma-Aldrich,
X1251) and ketamine (100 mg/kg; Sigma-Aldrich,
K1884) followed by allocation into 2 treatment
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Figure 1 Biological markers of inflammation and immunity correlating with our murine model of appendicitis (and appendectomy)
[24,25]. Appendicitis and appendectomy performed in the most proximal colon induce gene expression changes to curb T helper 17 cell
activities, curtail autophagy, modulate interferon activity-associated molecules, and suppress endothelin vasoactivity-mediated immunopathology/
vascular remodelling in the most distal colon. These contribute to the limitation/amelioration of colitis pathology.
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(3) Appendicitis is induced by constructing an
appendiceal pouch from the caecal lymphoid patch,
which is the equivalent of the human appendix.
 This appendiceal pouch (Figure 1) is obstructed
by rubber band ligation using standardised
negative aspiration.
(4) Sham surgery entails a similar procedure, but
without continuous obstruction by band ligation of
the caecal patch.
 It also involves the placement of a sterile rubber
band in the abdominal cavity as a control for
foreign body reaction.
 While most human ulcerative colitis patients
would not have undergone any form of
abdominal surgery at diagnosis, it is essential that
we control for the colonic and peritoneal milieu
changes induced by a simple laparotomy in our
experimental AA mice group.
 Additionally, the small rubber ring used to
encircle the main caecal follicle in the AA group
needs to be controlled for too. Hence, in each SS
group mouse, a rubber ring is introduced in the
peritoneal cavity via a small laparotomy incision.
(5) Seven days following initial surgery, appendicitis
mice undergo appendectomy (appendicitis andappendectomy, AA, group) by ligation and excision,
while sham mice undergo a second sham surgery
(sham and sham, SS, group).
(6) All mice are monitored daily.
(7) Distal colons are harvested (3 days or 14 days or 28
days post-AA) without the recta - a 1 cm-segment
(from the anus) are excluded prior to harvesting the
distal colon.
(8) Transmural distal colonic segments are chosen to
minimise artifactual changes and maximise
pathophysiological relevance; as not only superficial
mucosal tissue, but also colonic lymphoid nodules/
aggregations and other tissue may “transmit” the
protective immunological changes induced by
appendicitis and appendectomy to the distal colon.
 The proximal colon would be much more likely
to be affected by the inflammatory changes
experimentally induced by AA, owing to the close
anatomical proximity of the main mouse caecal
patch (≈human appendix) to the proximal colon.
 The novelty of our study is that the most distal
regions of the large gut sustain major persistent
immunological changes (protective against
colitis), by manipulation at the caecum, the most
proximal region of the large gut.
(9) The processing of transmural distal colonic samples
consists of flushing out of faecal contents with
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reagent (50-75 mg of tissue in 600 μL of TRIzol®
reagent; Invitrogen Australia Pty Limited, 15596-026),
snap-freezing in liquid nitrogen, and storing at −80°C
until the microarray analysis.
(10) After chloroform and isopropanol treatment and
centrifugation followed by washing the resultant
pellet with 75% ethanol, air-drying and final
re-constitution in nuclease-free H2O is done.
(11) Concentration and purity of RNA is determined by
automated optical density evaluation (OD 260/OD
280 ≥ 1.8 and OD 260/OD 230 ≥ 1.8) using
Nanodrop ND-1000 (Nanodrop Technologies,
Wilmington, DE, USA).
(12) The degree of RNA degradation is analyzed by the
Agilent electrophoresis bioanalyzer 2100 (Agilent
Technologies Inc, Santa Clara, CA, USA) with the
RNA integrity number (RIN) values consistently
above 7.
Protocol for mouse model of appendicitis
induction – procedure in steps
Apparatus required
(1) Fine forceps and scissors
(2) Autoclaved bands (rings) and transfer pipettes
(3) Suture holder and sutures (Needle Eithlon 4-0)
(4) Syringes and needles (22G)
(5) Surgical platform and sterile gloves
(6) Sterilised distilled water, Falcon tubes, and tube
holder frame
(7) P1000 pipettes and corresponding sterilized tips
(with prior tailor-made bevelling)
(8) Sterile dressing packs (plastic sheets; plastic blue
forceps, tray, sterile gauze)
(9) Shaving apparatus with shaving cream
Reagents required
(1) 50 ml of sterile Phosphate Buffered Saline (PBS)
(2) Sterile saline (Sodium Chloride Injections BP 0.9%
tubes)
(3) 5 ml anaesthetic stock solution composed of
Ketamine/xlyazine/sterile PBS - A standard 5 ml
anaesthetic stock solution would contain Ketamine
(100mg/ml) 1 ml, Xylazine (20mg/ml) 0.25 ml, and
Sterile PBS 3.75 ml.
 Ketamine (100 mg/ml) - 1ml for 100 mg/kg
 Xylazine (20 mg/ml) - 0.17 ml for 3.4 mg/kg OR
0.25 ml for 5 mg/kg
 Sterile PBS - 3.83 ml for 3.4mg/kg Xylazine OR
3.75 ml for 5 mg/kg Xylazine
(4) Spray bottle with 70% Ethanol
(5) Povidone-iodineProcedure steps
(1) Shave a circumscribed area of each mouse’s
abdomen (left side) a day before surgery.
(2) Weigh each mouse and make identification marks
on each mouse’s tail a day before surgery.
(3) Wrap each P1000 pipette with sterile plastic sheet
(from dressing pack).
(4) Anaesthetise mouse with ketamine/xylazine/sterile
PBS – Intraperitoneal injection of 0.1 ml of
anaesthetic stock solution per 20 g mouse weight.
(5) Prepare surgical area observing sterile conditions
meticulously:
 Use sterile gloves throughout.
 Cover bench with sterile plastic sheet and tape
the corners on the hood bench.
 Use sterile plastic forceps to pick up the
apparatus from the pack and put aside.
 Load autoclaved equipment onto sterile plastic
sheet by the “no touching” method.
 Load bands, and pour Povidone-iodine onto
sterile tray.
(6) Load band onto bevelled pipette tip with fine
forceps and set aside.
(7) Clean surgical platform with ethanol and place on
bench.
(8) Fix mouse to the platform by taping their arms/legs
with taps.
(9) Moist eyes with a drop of saline to prevent xerosis
and keratitis.
(10) Wipe abdomen with ethanol and clean the left part
of the shaved abdominal wall with Povidone-iodine.
(11) Cover mouse with the sterile draper from dressing
pack and make a hole in the draper above surgical
area with fine forceps.
(12) Perform a ~1cm laparotomy on the left sided
abdomen, using fine forceps to pick up skin and
peritoneum.
(13) Mobilise caecum out to the surface with blunt
curved forceps.
(14) Frequent moistening of the caecum with PBS is
essential.
(15) Identify the 2 to 4 white appendiceal lymphoid
patches, with one being far bigger than the others
– this would be the one to do the procedure on.
(16) Attach bevelled pipette tip with band to pipette,
and aspirate the lymphoid patch with firm suction
pressure in gentle, but firm circular motion.
Maintain suction pressure for 10 seconds before
slowly unloading the band (with fine forceps) onto
the neck of the newly created pouch.
 Include some colonic tissue during suction
because the created pouch will get smaller as
each mouse ages.
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abdominal cavity by gently grasping the band.
(18) Dispense 1ml of PBS in the abdominal cavity to
moisten the peritoneum.
(19) Suture the abdominal wall and the skin in layers.
(20) Give 1 ml normal saline subcutaneously (scruff of
neck) after the procedure.
(21) Place mice on their side and put them close to
each other in the cage to prevent hypothermia.
(22) Check post-op recovery in 1 hour for complete
recovery. Check recovery for 1 week post operation
and record observations in post operative period
table.
(23) Appendectomy is performed by 7 days after
appendicitis induction by gentle separation of
adhesions, ligation, and excision of the inflamed
area distal to the ligature.
(24) The mice are sacrificed 3 days or 14 days or 28
days after that for distal colon harvesting.
Data produced by this novel mouse model of
appendicitis and appendectomy - results and
discussion
Distal colonic gene expression studies; 3 days after sur-
gery, or 28 days after surgery; reveal the various genes
and gene-sets that are responsible for the durable
protective effect of AA against colitis [23]. The gene
expression data obtained from our study get more
distinct between the time-points (days 3, and 28), and
stabilise around day 28. Although observable in our
overall microarray results, these are visually appraised
better in the RT-PCR time-curves (days 3, 14, and 28)
of selected genes [23]. The persistence of these expression
changes would be theoretically easier to demonstrate in
humans than mice, as mice have an accelerated lifespan,
with 1 mouse year “often equated” to 30 human years.
The 28-day-extension of our studies is adequate to
demonstrate the chronological sustainability of these
changes.
Using this model, we have shown that AA performed
in the most proximal colon induces the following gene
expression changes in the most distal colon (Figure 1):
(1) Substantial curbing of T helper 17 cell -recruitment,
-differentiation, -activation, and –effector (interleu-
kin) expression contributing to suppression of Th17
pathway-mediated immunopathologial damage [24]
in colitis.
(2) Significantly and globally curbing autophagy gene
expression [25], contributing to suppression of
autophagy-mediated immunopathology in colitis.
(3) Late but significant suppression of genes and gene-
sets pertaining to endothelin activity - This would
suppress endothelin vasoactivity-mediatedimmunopathologial damage and vascular remodelling
in inflammatory colitis (Manuscript submitted).
(4) No changes in interferons; but upregulation of
genes pertaining to specific IFN activity-associated
molecules, and downregulation of genes pertaining
to other IFN activity-associated molecules
(Manuscript submitted).
Using our unique murine AA model, elucidating the
pathways involved in these changes will enhance the
development of approaches and techniques to manipulate
different genes, enzymes, and proteins related to these
pathways; towards improving therapeutic options in
IBD. Investigating strategies, involving monoclonal
antibodies, combinatorial peptides, and small molecules
(identified by high throughput screening) to manipulate
and modulate different aspects of these pathways,
would augment the development of new therapeutic
options to manage IBD.
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